Preferred Label : ependymoma;

MeSH definition : Glioma derived from EPENDYMOGLIAL CELLS that tend to present as malignant intracranial tumors in children and as benign intraspinal neoplasms in adults. It may arise from any level of the ventricular system or central canal of the spinal cord. Intracranial ependymomas most frequently originate in the FOURTH VENTRICLE and histologically are densely cellular tumors which may contain ependymal tubules and perivascular pseudorosettes. Spinal ependymomas are usually benign papillary or myxopapillary tumors. (From DeVita et al., Principles and Practice of Oncology, 5th ed, p2018; Escourolle et al., Manual of Basic Neuropathology, 2nd ed, pp28-9);

MeSH synonym : ependymomas;

CISMeF synonym : clear cell ependymomas; ependymoma, cellular; ependymoma, clear cell; cellular ependymomas; ependymomas, cellular; ependymomas, clear cell;

MeSH hyponym : ependymoma, papillary; cellular ependymoma; ependymoma, myxopapillary; anaplastic ependymoma; Ependymomas, Papillary; Papillary Ependymomas; Papillary Ependymoma; Ependymomas, Myxopapillary; Myxopapillary Ependymoma; Myxopapillary Ependymomas; Anaplastic Ependymomas; Ependymoma, Anaplastic; Ependymomas, Anaplastic; Clear Cell Ependymoma;

MeSH annotation : coordinate IM with precoordinated central nervous system/neoplasm term (IM) site (IM); MIXED OLIGODENDROGLIOMA-EPENDYMOMA see OLIGODENDROGLIOMA is also available;

Wikipedia link : https://en.wikipedia.org/wiki/Ependymoma;

Details


Main resources

You can consult :

Glioma derived from EPENDYMOGLIAL CELLS that tend to present as malignant intracranial tumors in children and as benign intraspinal neoplasms in adults. It may arise from any level of the ventricular system or central canal of the spinal cord. Intracranial ependymomas most frequently originate in the FOURTH VENTRICLE and histologically are densely cellular tumors which may contain ependymal tubules and perivascular pseudorosettes. Spinal ependymomas are usually benign papillary or myxopapillary tumors. (From DeVita et al., Principles and Practice of Oncology, 5th ed, p2018; Escourolle et al., Manual of Basic Neuropathology, 2nd ed, pp28-9)

https://campus.neurochirurgie.fr/article1717.html
2023
France
educational course
Newly Diagnosed Childhood Ependymoma
Childhood Ependymoma
ependymoma, nos
Intramedullary
Intramedullary Route of Administration
Adult Ependymoma
ependymoma

---
https://campus.neurochirurgie.fr/article1775.html
2023
France
audiovisual aids
ependymoma, nos
Newly Diagnosed Childhood Ependymoma
Adult Ependymoma
Childhood Ependymoma
ependymoma

---
https://campus.neurochirurgie.fr/article1744.html
2023
France
audiovisual aids
First Degree Family History Cancer Negative
No History of Non-Cardiac Surgery
KRAS Mutation Analysis Was Not Performed
No Known History of Illicit Drug Use
Family History of Stomach Cancer Absent
No Response to Intervention for Kawasaki Disease
Adjuvant Post-operative Chemotherapy Was Not Administered
New Tumor Event After Initial Treatment Absent
Adjuvant I-131 Therapy Negative
Radiation History Negative
NRAS Mutation Analysis Was Not Performed
Therapeutic Ionizing Radiation to Head History Absent
Has No Sibling
NCI CTEP SDC Ependymal Tumors Sub-Category Terminology
EGFR Mutation Analysis Was Not Performed
Adjuvant Post-operative Immunological Therapy Was Not Administered
No History of Rheumatic Fever
Physician Diagnosed Diabetes Absent
Preoperative IV Antiemetics were not Administered
PDGFRA Mutation Analysis Was Not Performed
Patient was Not Previously Evaluated for Current Chief Complaint
No History of Neonatal Complication
ROS1 Rearrangement Analysis Was Not Performed
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Intercurrent Illness is Absent at Onset of Chief Complaint
TP53 Mutation Analysis Was Not Performed
ATRX Mutation Analysis Was Not Performed
10q23/PTEN Locus Deletion Analysis Was Not Performed
Chief Complaint Not Caused by Trauma
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Evidence of Disease Absent after Completion of Therapy
Other Preoperative IV Medications were not Administered
Additional Surgery for New Tumor Event Absent
Preoperative IV Antacids were not Administered
ependymoma, nos
Nitric Oxide
New Disease is not Multifocal
No History of Kawasaki Disease
ERBB2 Mutation Analysis Was Not Performed
Not Lost to Follow-Up
Lymph Node Dissection Was Not Performed
No History of Gestational Complication
RET Rearrangement Analysis Was Not Performed
KIT Mutation Analysis Was Not Performed
Intervention Not Given for Kawasaki Disease
First Degree Family History of Primary Brain Tumor Negative
Adjuvant Post-operative Radiation Therapy Was Not Administered
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
BRAF Mutation Analysis Was Not Performed
History of Colorectal Cancer Negative
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Chemical/Occupational Exposure Absent
Regional Anesthesia was not Administered
Additional Molecular Studies Were Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
SDH Complex Mutation Analysis Was Not Performed
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Regular Smokeless Tobacco Use for Six Weeks or More Negative
MGMT Promoter Methylation Testing Was Not Performed
NON Mouse
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Medication Not Taken
Neither
Hypertension Absent
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Preoperative IV Sedation was Not Administered
Neither Case or Control Status
Preoperative IV Opiates were not Administered
Chief Complaint was Not Witnessed
Chemotherapy Not Received
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Radiation Therapy Not Received
Paraneoplastic Syndrome is Not Present
History of Medical Treatment Absent
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Documentation Absent
Caffeine Not Routinely Consumed
Use of Smokeless Tobacco at Time of Diagnosis Negative
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
IDH Family Wildtype
ependymoma
IV Anesthesia was not Administered
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Negation
1p/19q Deletion Analysis Was Not Performed
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
ATRX Gene Mutation Negative
Another Form of Birth Control was not Used
Norway
Fluorescence In Situ Hybridization Was Not Performed
EGFR Gene Amplification Negative
ALK Rearrangement Analysis Was Not Performed
Patient was not Postmenopausal with no Prior Oophorectomy
No History of Myopathy
No History of Congenital Heart Disease
Minor Criteria for Rheumatic Heart Disease Not Present
PTEN Mutation Analysis Was Not Performed
Routine Cytogenetics Were not Completed
First Degree Family History Thyroid Cancer Negative
Cancer History Absent
No Known History of Alcohol Use
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Any Metastatic Diagnosis Absent
Unemployed
Tumor Reoccurrence Absent After Initial Treatment
BRAF Rearrangement Analysis Was Not Performed
Local Anesthesia Agents were not Administered
NF1 Mutation Analysis Was Not Performed
Tumor Progression Absent After Initial Treatment
PTEN Gene Mutation Negative
MET Mutation Analysis Was Not Performed
Nitric Oxide Measurement
EGFR Amplification Analysis Was Not Performed
Additional Immunohistochemistry Was Not Performed
IDH Family Mutation Analysis Was Not Performed
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered

---
https://neuro-dev.unilim.fr/spip.php?article1633
2022
France
educational course
General aspects
General aspects
General aspects
General
General
General aspects
Tumors
General
General aspects
General
General aspects
General
General aspects
General
General aspects
General aspects
General aspects
General aspects
General concepts
General aspects
General
Tumors
General aspects
General aspects
General aspects
Generalities
General
Generalities
General aspects
General topics
General
General points
General aspects
Generalities
spinal cord neoplasms
General aspects
Tumors
Generalities
General concepts
General
General aspects
Generalities
General points
General aspects
General aspects
General aspects
General points
General aspects
Generalities
ependymoma, nos
General
General aspects
General aspects
Tumors
General aspects
Generalities
General points
General
General
General aspects
General aspects
General aspects
General concepts
General aspects
General aspects
General
General aspects
Tumor
General aspects
Generalities
General aspects
General aspects
Generalities
Tumors
Tumors
Generalities
General
General aspects
ependymoma
Generalities
General aspects
General aspects
Generalities
General aspects
General
General points
General concepts
General
Generalities
General aspects
General aspects
General aspects
General points
General
General aspects
General
General
General aspects
General
Generalities
General aspects
General aspects
General aspects
General aspects
General
General
General aspects
General points
General aspects
General
General aspects
General subjects
General
General aspects
Generalities
General aspects
General aspects
General
General aspects
General aspects
Generalities
General points
General aspects
General aspects
General
General
General aspects
General concepts
General aspects
General aspects
Tumors
General aspects
General aspects
General aspects
Generalities
General concepts
Tumors
General aspects
General
Generalities
Tumors
General aspects
General
Tumors
Tumors
General

---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=251646
2011
France
scientific and technical information
ependymoma, nos
ependymoma

---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=251639
2011
France
scientific and technical information
ependymoma, nos
ependymoma

---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=251636
2011
France
scientific and technical information
ependymoma
ependymoma, nos

---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=251633
2011
France
scientific and technical information
ependymoma
ependymoma, nos
barium sulfide

---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=251643
2011
France
scientific and technical information
ependymoma
ependymoma, nos

---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=301
2004
false
true
false
France
scientific and technical information
ependymoma

---
http://www.john-libbey-eurotext.fr/fr/revues/medecine/bdc/e-docs/00/03/FC/B9/article.md?type=text.html
2002
France
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
glioma
glioma
glioma
glioma
glioma
glioma
glioma
glioma
glioma
glioma
brain neoplasms
brain neoplasms
brain neoplasms
brain neoplasms
brain neoplasms
brain neoplasms
brain neoplasms
brain neoplasms
brain neoplasms
brain neoplasms
risk factors
adult
diagnostic imaging
postoperative care
glioblastoma
glioblastoma
astrocytoma
astrocytoma
oligodendroglioma
oligodendroglioma
neoplasms, neuroepithelial
neoplasms, neuroepithelial
glioma, subependymal
glioma, subependymal
brain stem neoplasms
brain stem neoplasms
prognosis
activities of daily living
palliative care
brain neoplasms
incidence
glioma
occupational exposure
environmental exposure
molecular biology
glioma
oligodendroglioma
ependymoma
magnetic resonance imaging
tomography, emission-computed
tomography, emission-computed, single-photon
glioma
treatment outcome
continuity of patient care
neoplasm, residual
biopsy
survival rate
brachytherapy
radiotherapy
neoplasm metastasis
age factors
quality of life
neoplasm recurrence, local
neoplasm staging
tomography, X-ray computed
sex distribution
ependymoma
ependymoma
bibliography of medicine
radiotherapy
radiotherapy
glucocorticoids
Evidence-Based medicine
practice guideline
table
journal article
algorithms
brain neoplasms
glioma

---
Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.